Top Markets
#1 Fake World Assets Fake World Assets +11.84%
#2 TENDIES TENDIES +6.51%
#3 Janction Janction +5.07%
#4 GoPlus Security GoPlus Security +4.45%
#5 B3 (Base) B3 (Base) +4.30%
#6 Status Status +4.24%
#7 Everything Everything +3.72%
#8 TronBank TronBank +3.26%
#9 Cross Cross +2.99%
#10 Tutorial Tutorial +2.63%
Coin of the day
Fake World Assets Fake World Assets
Settings
Language
ENGLISH
Currency
USD
Theme
COSCIENS Biopharma Inc. COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.

CSCI
Rank in Stocks #34152
COSCIENS Biopharma Inc., a life science company, develops and commercializes... COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Share Price
$5.78
Last synced: 2026-08-14
Market Cap
$6.14M
Change (1 day)
0.25%
Change (1 year)
-32.55%
Country
CA
Trade COSCIENS Biopharma Inc. (CSCI)

Category

Healthcare
Revenue for COSCIENS Biopharma Inc. (CSCI)
Revenue in Aug 2026 TTM: 0
According to COSCIENS Biopharma Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for COSCIENS Biopharma Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US